Back to MORGAN STANLEY MORGAN STANLEY

CNTACNTA
Showing 8 of 9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in CENTESSA PHARMACEUTICALS PLC

MORGAN STANLEY previously held 0 shares of CNTA (CENTESSA PHARMACEUTICALS PLC), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$22.1M

Total Shares Change

-1.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$40.50
0
2026-Q1
Increased
4.3M
+284.9%
$169.5M0.0%$26.20
49
2025-Q4
Decreased
1.1M
-1.4%
$27.7M0.0%$24.74
0
2025-Q3
Decreased
1.1M
-37.3%
$27.3M0.0%$24.40
0
2025-Q2
Decreased
1.8M
-38.9%
$23.6M0.0%$13.13
0
2025-Q1
Increased
2.9M
+52.6%
$42.2M0.0%$14.59
41
2024-Q4
Increased
1.9M
+39.5%
$32.2M0.0%$16.35
38
2024-Q3
Decreased
1.4M
-32.7%
$22.1M0.0%$15.79
0

Other major holders of CNTA: Avoro Capital Advisors LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Pentwater Capital Management LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used